New York students K-12 will have the opportunity for COVID-19 testing prior to or at the start of the 2021-2022 school year through Rite Aid and BioReference CAMP HILL, Pa. (August 26, 2021) – Rite Aid (NYSE: RAD) and the U.S. Department of Health and Human Services (HHS), together with BioReference Laboratories, Inc., an OPKO Health […]
Search Results for: FORM
ELMWOOD PARK, N.J., August 16, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. Ariosa’s non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in […]
This month, we are striving to bring awareness to Spinal Muscular Atrophy (SMA), a serious inherited condition caused by changes in the SMN1 gene, which controls motor neurons in the spinal cord and brainstem. Symptoms can begin prior to six months of age, in childhood, or, more rarely, in adulthood. In the most common form […]
Return To School Safely As we continue through the dog days of summer, many parents, teachers and administrators are shifting gears to back-to-school season, and thinking about what in-person learning may look like amidst the COVID-19 pandemic. Testing students will be key for schools looking to re-open, as many primary and secondary education students are […]
The time has finally come where COVID-19 restrictions are being lifted across the country and for the first time in over a year we are able to get together with friends and family, attend big events, and travel. While vaccination rates are continuing to increase, there is also the risk of the new Delta variant […]